Genome binding/occupancy profiling by high throughput sequencing
Summary
Three triple negative breast cancer cell lines (MDAMB231, SUM159, and HCC1806) were treated with small molecule inhibitors (JQ1, BET bromodomain inhibitor; GSK2801, BAZ2A/B bromodomain inhibitor) or BAZ siRNA alone and in combination with JQ1 for 48 hours
Overall design
34 experimental samples analyzed, 2 chromatin input control samples